Table 3.
Summary of advantages and challenges of PTT in cancer treatment
| Advantages | Challenges |
|---|---|
| Photo-responsive materials are localized in the tumor area. [118, 119] Targeting ligands such as antibodies, single-chain fragments of antibodies, carbohydrates, etc. can be furnished on AuNPs to combat low targeting ability [81] | Low targeting ability due to the hindrance caused by the dense interstitial structure of the tumor and lack of vessels in the tumor [80] and defects of photosensitive materials [120] |
| Produces high local temperatures with no or minimal influence on healthy cells and tissues [119] | Possible thermal damage to normal tissue [120] |
| PTT can be combined with other types of therapies with different mechanisms of action, which results in a synergetic treatment effect [5, 88, 121] | Insufficient photothermal effect and limited penetration depth of light in biological tissues [88, 120] |
| Upgradable thermal capacity is achieved by manipulating the size of gold nanoparticles and modifying their surface properties for the targeted location of the tumor [78] | Poor photothermal stability [78]. Can lose their photothermal conversion ability upon repetitive NIR radiation [79] |
| Compensate for poor drug loading capacity with remarkable light-absorbing and scattering abilities [67] | AuNPs have a poor drug loading capacity, limiting the use of AuNPs as drug carriers [79] |